comparemela.com

Sanofi Adr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sell AstraZeneca, says UBS, which upgrades European rivals including GSK

UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of AstraZeneca and a double-upgrade of U.K. rival GSK.

City ofUnited kingdomNovo nordiskMatthew westonArticle normalBiotechnology servicesHealthcare life sciencesAerospace defenseDefense equipment productsIndustrial goodsCorporate strategy planningAnalyst comment recommendationCorporate industrial newsContent typesFactiva filtersC amp ampe exclusion filter

MeiraGTx shares jump as Sanofi invests in gene therapy

Sanofi may use company's gene regulation technology in immunology, metabolic disease and other conditions

Paul hudsonMeiragtx riboswitchScribe therapeutics incMeiragtx holdingsArticle normalBiotechnology servicesHealthcare life sciencesBiological therapyHealthcare provisionRegulation government policyFinancial performanceShare price movement disruptionsOwnership changesAcquisitions mergers shareholdingsCorporate actionsCorporate industrial news

Sanofi shares skid as French drugmaker outlines higher R&D expenses, taxes

Shares of French drugmaker Sanofi fell as much as 16% on Friday after hiking its research-and-development expense guidance as well as its expectations for.

Paul hudsonArticle normalHealthcare life sciencesFinancial performanceCorporate industrial newsContent typesFactiva filtersC amp ampe industry news filterSanofi saFr sanSanofi adrIndustrial newsLife sciences

Sanofi reaps rewards of immunology investment with eczema results

Pharmaceutical giant set to take on Amgen with atopic dermatitis treatment.

David risingerNaimish patelAmgen incRegeneron pharmaceuticals incVenereology congressEuropean academy of dermatologyEuropean academyRegeneron pharmaceuticalsKyowa kirinLeerink partnersArticle normalBiotechnology servicesHealthcare life sciencesCorporate industrial newsPolitical general newsMedical treatments procedures

Teva partnership with Sanofi will pay dividends, analyst says

Collaboration on inflammatory bowel disease treatment seen as a 'hot asset'

Teva pharmaceutical industries ltdMerck coTeva pharmaceutical industriesPrometheus biosciencesUmer raffatArticle normalBiotechnology servicesHealthcare life sciencesGeneric biosimilar drugsFinancial performanceCorporate actionsCorporate industrial newsPartnerships collaborationsAutoimmune diseasesPolitical general newsGenetic disorders

vimarsana © 2020. All Rights Reserved.